Patents by Inventor Kimberly Mauck

Kimberly Mauck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7297515
    Abstract: Novel zinc finger proteins and nucleic acids encoding the proteins are provided. The zinc finger proteins interact with ZNF202, a zinc finger protein that regulates the expression of a variety of genes involved in lipid metabolism and transportation. Modulation of the novel zinc finger proteins and their interactions with ZNF202 can be useful in the treatment of coronary heart diseases, dyslipidemia, dyscholesterolemia and obesity.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: November 20, 2007
    Assignee: Myriad Genetics, Inc.
    Inventors: Philippe Szankasi, Kimberly Mauck, Daniel Albert Wettstein
  • Publication number: 20070254300
    Abstract: Protein complexes are provided comprising at least one interacting pair of proteins. The protein complexes are useful in screening assays for identifying compounds effective in modulating the protein complexes, and in treating and/or preventing diseases and disorders associated with the protein complexes and/or their constituent interacting members.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 1, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Daniel Cimbora, Karen Heichman, Paul Bartel, Kimberly Mauck, Angie Bush
  • Publication number: 20050112118
    Abstract: Protein complexes are provided comprising at least one interacting pair of proteins. The protein complexes are useful in screening assays for identifying compounds effective in modulating the protein complexes, and in treating and/or preventing diseases and disorders associated with the protein complexes and/or their constituent interacting members.
    Type: Application
    Filed: October 20, 2003
    Publication date: May 26, 2005
    Applicant: Myriad Genetics, Incorporated
    Inventors: Daniel Cimbora, Karen Heichman, Paul Bartel, Kimberly Mauck, Angie Bush
  • Patent number: 6653102
    Abstract: The present invention relates to the discovery of protein—protein interactions that are involved in the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD). Thus, the present invention is directed to complexes of these proteins and/or their fragments, antibodies to the complexes, diagnosis of neurodegenerative disorders (including diagnosis of a predisposition to and diagnosis of the existence of the disorder), drug screening for agents which modulate the interaction of proteins described herein, and identification of additional proteins in the pathway common to the proteins described herein.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: November 25, 2003
    Assignee: Myriad Genetics, Inc.
    Inventors: Jean-Marc Roch, Paul L. Bartel, Karen Heichman, Kimberly Mauck, Max Dufford
  • Publication number: 20030036163
    Abstract: Novel PN9826 protein and nucleic acids encoding PN9826 are provided. PN9826-containing protein complexes formed by PN9826 and a PN9826-interacting protein (e.g., LTBP1) are also provided. LTBP1 and PN9826 may be involved in common biological processes such as angiogenesis, metastasis, and cell growth and adhesion. Thus, the protein complexes as well as PN9826 can be used in screening assays to select modulators of PN9826 and the protein complexes formed by PN9826 and LTBP1. The identified modulators can be useful in modulating the functions and activities of PN9826 and protein complexes containing PN9826.
    Type: Application
    Filed: July 10, 2002
    Publication date: February 20, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Daniel Albert Wettstein, Kimberly A. Mauck